Thursday, October 31, 2024

1:30 PM - 2:15 PM

---

Details

This session will explore the current state of Australia’s clinical trial landscape and its potential for revitalisation. Experts will address whether Australia is facing a clinical trial slump by examining performance trends in early, mid and late-stage trials and discuss ways to strengthen our position. Key topics include: Attracting Global Sponsors Enhancing Australia’s appeal to global Bio/Medtech companies through improved   incentives, better trial site contracts, competitive insurance and government support programs. The Role of Technology and Diversity in Accelerating Trials With its vast geography, Australia has strong potential to pioneer virtual trials, telemedicine and remote data collection. The session will explore how to reflect greater diversity in clinical trials by targeting underrepresented groups and collaborating with neighbouring countries. Global Comparisons and Lessons from Abroad Learning from comparable countries to regain Australia’s competitive edge. Cost Competitiveness, Sustainability and Future-Proofing Evaluating cost-competitiveness, sustainability considerations and future-proofing measures that could shape the future of Australia’s clinical trial industry. This session aims to inspire discussion on reclaiming Australia’s leadership in global clinical trials.

---

Speaker